Heikrujam Thoihen Meitei
Also known as: Thoihen
Roswell Park Comprehensive Cancer, National Centre for Cell Science
About
Heikrujam Thoihen Meitei currently works at the Department of Medicine Roswell Park Cancer Center, Buffalo, New York as a Research Affiliate (Post-Doc). He obtained his PhD degree in Biotechnology from National Centre For Cell Science, Pune, India. Thoihen is currently working on CAR T cells. Thoihen did his PhD research in Autoimmunity, Molecular Biology and Cell Biology. Their most recent publication is 'CCR6 signaling inhibits suppressor function of induced-Treg during gut inflammation.' and 'CCR6-CCL20 axis as a therapeutic target for autoimmune diseases.'
Employment
-
Roswell Park Comprehensive Cancer Research Affiliate (Post-Doc)2022 - 2027
-
National Centre for Cell Science SRF2016 - 2022
-
National Centre for Cell Science SRF2016 - 2022
Education
-
National Centre for Cell Science PhD2016 - 2022
Projects & Funding
Projects & funding information is unavailable.
Publications (13)
- Impact of stromal-targeting antitumor CAR T cells in solid tumors. Save
- Th17 cell promotes apoptosis of IL-23R+neurons in experimental autoimmune encephalomyelitis Save
- RORψt+CD4+T cells promote IL-23R-mediated neuronal cell apoptosis in the central nervous system Save
- Complement C3 deficiency enhances the effector function of CD8+T cells and inhibits tumour growth Save
- Vγ2+ γδ T Cells in the Presence of Anti-CD40L Control Surgical Inflammation and Promote Skin Allograft Survival Save
- Protective role of host complement system in Aspergillus fumigatus infection. Save
- In vitro-induced Foxp3+ CD8+ regulatory T cells suppress allergic IgE response in the gut. Save
- T cell receptor signaling in the differentiation and plasticity of CD4+ T cells. Save
- Anti-CD40L Antibody Promotes the Differentiation of Vy2+Regulatory Gamma-delta T Cells and Prolongs the Survival of Skin Allografts Save
- COMPLEMENT C3 DEFICIENCY INCREASES THE ANTITUMOR IMMUNITY OF NK CELLS AND CONTROLS TUMOR GROWTH Save